Literature DB >> 3782202

Core decompression of the femoral head for osteonecrosis.

J F Camp, C W Colwell.   

Abstract

The results of forty core-decompression procedures that were performed for ischemic necrosis of the femoral head in thirty-one patients over a four-year period were retrospectively reviewed to ascertain the effectiveness of the procedure. The data did not support the published rates of success of the procedure for Stage-1 and Stage-2 lesions. With a mean length of follow-up of eighteen months, 60 per cent of the hips that had a decompression prior to collapse of the femoral head demonstrated progression of the lesion and were judged to be a failure by clinical or radiographic criteria. Computerized tomographic scans and magnetic resonance imaging proved to be 100 per cent sensitive for diagnosis in preoperative testing; isotopic bone-scanning was less sensitive (80 per cent). Functional intraoperative testing by the method of Ficat did not provide added sensitivity or specificity to the results of the preoperative bone scan. A postoperative or intraoperative fracture occurred in four hips, for an incidence that exceeded any in previously published reports. We concluded that core decompression should be considered a relatively ineffective procedure with significant morbidity.

Entities:  

Mesh:

Year:  1986        PMID: 3782202

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  28 in total

1.  Clinical and radiological outcome of the treatment of osteonecrosis of the femoral head using the osteonecrosis intervention implant.

Authors:  Thilo Floerkemeier; Fritz Thorey; Dorothea Daentzer; Matthias Lerch; Phillip Klages; Henning Windhagen; Gabriela von Lewinski
Journal:  Int Orthop       Date:  2010-01-30       Impact factor: 3.075

2.  Core decompression and osteonecrosis intervention rod in osteonecrosis of the femoral head: clinical outcome and finite element analysis.

Authors:  Thilo Floerkemeier; André Lutz; Udo Nackenhorst; Fritz Thorey; Hazibullah Waizy; Henning Windhagen; Gabriela von Lewinski
Journal:  Int Orthop       Date:  2010-10-24       Impact factor: 3.075

3.  Frequency of idiopathic aseptic necrosis in medically treated alcoholics.

Authors:  D Orlić; S Jovanović; D Anticević; J Zecević
Journal:  Int Orthop       Date:  1990       Impact factor: 3.075

4.  [Navigated drilling for femoral head necrosis. Experimental and clinical results].

Authors:  J Beckmann; M Tingart; L Perlick; C Lüring; J Grifka; S Anders
Journal:  Orthopade       Date:  2007-05       Impact factor: 1.087

5.  Comparative study of bone growth by pulsed electromagnetic fields.

Authors:  T D Gupta; V K Jain; P N Tandon
Journal:  Med Biol Eng Comput       Date:  1991-03       Impact factor: 2.602

6.  Analysis of outcome of avascular necrosis of femoral head treated by core decompression and bone grafting.

Authors:  Smit N Shah; Chirag S Kapoor; Maulik R Jhaveri; Paresh P Golwala; Sagar Patel
Journal:  J Clin Orthop Trauma       Date:  2015-05-01

7.  The diagnostic challenge of acute polyarthritis.

Authors:  I A Wamuo; P I Pitt
Journal:  Ann Rheum Dis       Date:  1996-05       Impact factor: 19.103

8.  Assessing the accuracy of a prototype drill guide for fibular graft placement in femoral head necrosis.

Authors:  M J Schnieders; S B Dave; D E Morrow; A D Heiner; D R Pedersen; T D Brown
Journal:  Iowa Orthop J       Date:  1997

9.  Outcome of painful bone marrow edema of the femoral head following treatment with parenteral iloprost.

Authors:  Roland Meizer; Dominik Meraner; Elisabeth Meizer; Christian Radda; Franz Landsiedl; Nicolas Aigner
Journal:  Indian J Orthop       Date:  2009-01       Impact factor: 1.251

10.  Outcome after tantalum rod implantation for treatment of femoral head osteonecrosis: 26 hips followed for an average of 3 years.

Authors:  Sokratis E Varitimidis; Apostolos P Dimitroulias; Theophilos S Karachalios; Zoe H Dailiana; Konstantinos N Malizos
Journal:  Acta Orthop       Date:  2009-02       Impact factor: 3.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.